We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Improved Tool Concentrates Tubercle Bacilli

By LabMedica International staff writers
Posted on 07 Jun 2012
A tiny filter could have a big impact around the world in the fight against tuberculosis (TB) as it detects more cases of the bacterial infection. More...


The novel technique, which involves vacuum filtering a sputum sample treated with household bleach and other simple chemicals through a small filter, could dramatically improve TB diagnoses globally, particularly in settings where the disease is common and resources are limited.

A lung disease specialist, now at the University of Florida (UF; Gainesville, FL, USA) with colleagues at the Federal University of Espírito Santo (Vitória, Brazil), used the traditional microscope-based diagnosis method as a starting point, and devised a way to identify more cases of the Mycobacterium tuberculosis infection. The most widely used way to confirm TB infection is to use a microscope to identify and count disease-causing bacteria in sputum smeared onto a glass slide. Although the method has been in continuous use for more than a century, it can be unreliable, on average catching cases only about half of the time.

Part of the problem is that sometimes sputum samples do not contain many bacteria, making it hard to detect TB. Concentrating bacteria onto a small area could help improve detection accuracy, and although previous efforts have led to improvements, they tend to require expensive equipment or technical knowhow. In some cases, gains were offset by loss of sample or safety concerns. Therefore, the quest for a low-cost, simple, effective method led back to the trusty microscope. The scientists decided to try 13 mm polycarbonate membrane filters with 1.0 µm pores, that fit neatly onto microscope slides and that concentrated the bacteria even more.

For the 314 patients in Brazil suspected as having TB, but not yet in treatment, the team modified small-filter method by adding 95% ethanol and 1% Triton X detergent to the bleach, using filters with an 0.8 µm pore size, and prefiltering the sputum digests through 25 mm polypropylene prefilters with 30 µm pores (Millipore, Billerica, MA, USA). This method detected 89% of cases, compared with 60 % detection when samples were concentrated by the currently used method of rapid spinning, and 56% detection when sputum smears were looked at directly under the microscope. Furthermore, the small-filter method identified almost three-quarters of TB-positive cases that had been incorrectly reported as negative based on the traditional technique.

Kevin Fennelly, MD, MPH, an associate professor in the UF College of Medicine, said, "A point-of-care dipstick that can say yes or no is the Holy Grail, but we're a long way from there. ‘Microscope’ has become a dirty word in the TB diagnostics world, but almost every clinical laboratory in the world has one.” The method is being tested in western Uganda, where many people have both TB and HIV. They are comparing it again with the traditional direct-smear method and with a sophisticated DNA-based test that can also detect whether bacteria are drug resistant. The study was published in the June 2012 issue of the Journal of Clinical Microbiology.

Related Links:
University of Florida
Federal University of Espírito Santo
Millipore


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.